Who owns IMPEL NEUROPHARMA INC?
- Ticker: IMPLQ
- CUSIP Number: 45258k109
Tip: Access positions for across all investors
Analyze quarterly positions in Impel Neuropharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Impel Neuropharma stock
Who bought or sold IMPEL NEUROPHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
venBio Partners | 2.8M | $341k | 0% | Dec 2023 |
|
D. J. St. Germain | 1.5k | $184.950000 | 0% | Dec 2023 |
|
Who sold out of Impel Neuropharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Kohlberg Kravis Roberts & Co | Sep 2023 | 4.1M | $1.8M |
NVP Associates | Sep 2023 | 3.1M | $1.3M |
5AM Venture Management | Sep 2023 | 2.9M | $1.2M |
Vivo Capital | Sep 2023 | 2.9M | $1.2M |
Vanguard Group | Sep 2023 | 505k | $217k |
Bank of New York Mellon | Sep 2023 | 35k | $15k |
Millennium Management | Sep 2023 | 22k | $9.2k |
Two Sigma Securities | Sep 2023 | 21k | $8.8k |
Virtu Financial | Sep 2023 | 16k | $7.0k |
Raymond James & Associates | Sep 2023 | 15k | $6.2k |
Captrust Financial Advisors | Sep 2023 | 14k | $6.2k |
Brighton Jones | Sep 2023 | 14k | $6.1k |
Lindbrook Capital | Sep 2023 | 3.1k | $1.3k |